Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (HKG:2667)
Hong Kong · Delayed Price · Currency is HKD 2.445
-0.120 (-4.68%)
At close: Sep 1, 2026
HKG:2667 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,099 | 1,171 | 1,175 | 1,153 | 910.98 | |
Revenue Growth | - | -0.32% | 1.91% | 26.58% | - |
Cost of Revenue | 887.9 | 949.51 | 952.62 | 935.65 | 768.21 |
Gross Profit | 210.68 | 221.81 | 222.5 | 217.48 | 142.77 |
Selling, General & Admin | 157.62 | 157.24 | 173.93 | 160.43 | 148.66 |
Other Operating Expenses | -6.88 | - | - | - | -15.85 |
Operating Expenses | 151.38 | 157.88 | 173.61 | 160.61 | 132.81 |
Operating Income | 59.3 | 63.93 | 48.89 | 56.87 | 9.96 |
Interest Expense | -11.66 | -12.98 | -14.28 | -11.29 | -7.27 |
Interest & Investment Income | 2.3 | 2.3 | 2.91 | 4.12 | 3.88 |
Earnings From Equity Investments | -0.22 | 0.1 | 0.11 | 2.03 | 0.31 |
Other Non Operating Income (Expenses) | -3.87 | -3.68 | -0.58 | 11.24 | -0.86 |
EBT Excluding Unusual Items | 45.86 | 49.66 | 37.04 | 62.97 | 6.02 |
Merger & Restructuring Charges | - | - | -0.41 | - | -0.72 |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | 17.01 | -0.02 | -0.4 |
Other Unusual Items | -1.37 | -1.37 | 7.74 | 2.53 | 1.31 |
Pretax Income | 44.45 | 48.25 | 61.38 | 65.48 | 6.21 |
Income Tax Expense | 14.25 | 14.5 | 15.18 | 22.85 | 15.45 |
Earnings From Continuing Operations | 30.2 | 33.75 | 46.2 | 42.63 | -9.23 |
Minority Interest in Earnings | -5.57 | -6.27 | -9.34 | -20.3 | -7.06 |
Net Income | 24.63 | 27.48 | 36.86 | 22.34 | -16.3 |
Net Income to Common | 24.63 | 27.48 | 36.86 | 22.34 | -16.3 |
Net Income Growth | - | -25.46% | 65.02% | - | - |
Shares Outstanding (Basic) | 357 | 357 | 343 | 300 | 267 |
Shares Outstanding (Diluted) | 357 | 357 | 343 | 300 | 267 |
Shares Change | - | 4.17% | 14.30% | 12.50% | - |
EPS (Basic) | 0.07 | 0.08 | 0.11 | 0.07 | -0.06 |
EPS (Diluted) | 0.07 | 0.08 | 0.11 | 0.07 | -0.06 |
EPS Growth | - | -28.44% | 44.37% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 21.79 | 102.87 | 75.85 | 64.68 | -7.39 |
Free Cash Flow Per Share | 0.06 | 0.29 | 0.22 | 0.22 | -0.03 |
Gross Margin | 19.18% | 18.94% | 18.93% | 18.86% | 15.67% |
Operating Margin | 5.40% | 5.46% | 4.16% | 4.93% | 1.09% |
Profit Margin | 2.24% | 2.35% | 3.14% | 1.94% | -1.79% |
Free Cash Flow Margin | 1.98% | 8.78% | 6.46% | 5.61% | -0.81% |
EBITDA | 87.72 | 91.47 | 76.18 | 85.7 | 38.76 |
EBITDA Margin | 7.98% | 7.81% | 6.48% | 7.43% | 4.25% |
D&A For EBITDA | 28.41 | 27.54 | 27.3 | 28.82 | 28.8 |
EBIT | 59.3 | 63.93 | 48.89 | 56.87 | 9.96 |
EBIT Margin | 5.40% | 5.46% | 4.16% | 4.93% | 1.09% |
Effective Tax Rate | 32.05% | 30.05% | 24.73% | 34.89% | 248.61% |
Advertising Expenses | - | 1.84 | 2.67 | 3.68 | 1.39 |